94768-9

SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay

Active

Term Description

Qualitative detection of IgA antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum, plasma or whole blood by rapid immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Description

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgA
Property: PrThr
Time: Pt
System: Ser/Plas/Bld
Scale: Ord
Method: IA.rapid

Additional Names

Short Name: SARS-CoV-2 IgA SerPlBld Ql IA.rapid
Display Name: SARS-CoV-2 (COVID-19) IgA IA.rapid Ql (S/P/Bld)
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgA antibody, Blood

Ask at Order Entry

81959-9 Public health laboratory ask at order entry panel

This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.

LOINC	Name	R/O/C	Example UCUM Units
81959-9	Public health laboratory ask at order entry panel
Indent81744-5	Submitter's laboratory test method [Type] in Specimen
Indent81658-7	Suspected organism [Identifier] in Specimen
Indent86952-9	Preliminary testing done Specimen
Indent86953-7	Preliminary testing result Specimen
Indent86955-2	Preliminary testing affected submission for further testing Specimen
Indent95417-2	Whether this is the patient's first test for condition of interest
Indent95418-0	Whether patient is employed in a healthcare setting
Indent95419-8	Whether the patient has symptoms related to condition of interest
Indent11368-8	Illness or injury onset date and time	C
Indent77974-4	Whether the patient was hospitalized for condition of interest
Indent95420-6	Whether the patient was admitted to intensive care unit (ICU) for condition of interest
Indent95421-4	Whether patient resides in a congregate care setting
Indent82810-3	Pregnancy status	C
Indent30525-0	Age		a

Example Answer List: LL3713-6

Source: Mercy Genesis

Answer	Code	Score	Answer ID
Detected			LA11882-0
Not detected			LA11883-8
EquivocalCopyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value)			LA11885-3
InvalidCopyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value)			LA15841-2

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Observation

Member of these Panels

LOINC	Long Common Name
94503-0	SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgA:Nachweis oder Schwellenwert:Zeitpunkt:Serum, Plasma oder Blut:Ordinal:Immunoassay.schnell
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgA:PrThr:Punto temporal:Suero, Plasma o Sangre:Ord:IA.rapid
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgA:Presencia o umbral:Punto temporal:Suero, plasma o sangre:Ordinal:Inmunoensayo rápido
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgA:Présence/Seuil:Ponctuel:Sérum/Plasma/Sang:Qualitatif:Immunoanalyse rapide
fr-CA	French (Canada)	coronavirus 2 du SRAS, IgA:Présence-Seuil:Temps ponctuel:Sérum/Plasma/Sang:Ordinal:IA.rapide
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgA:PrThr:Pt:Siero/Plasma/Sangue:Ord:IA.rapido Synonyms: anticorpi anti-IgA anticorpo Coronavirus della SARS Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Siero Siero o Plasma Siero,Plasma o Sangue
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgA:aanwezigheid:moment:serum of plasma of bloed:ordinaal:immunoassay.sneltest Synonyms: antistof; antilichaam IA IA.rapid SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgA:granica wykrywalności:punkt w czasie:surowica, osocze lub krew:półilościowy:szybka metoda immunologiczna Synonyms: Immunoglobulina A Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgA do SARS-CoV-2 (COVID-19) (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgA:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫测定法.快速 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgA;IgA;抗体 IgA Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 A 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）快速免疫测定;快速免疫测定法;快速免疫分析法;快速免疫检定法;快速免疫检定;快速免疫试验;酶免疫测定法.快速;快速酶免疫测定法;快速酶免疫测定;快速酶免疫分析法;快速酶免疫检定法;快速酶免疫检定;快速酶免疫试验时刻;随机;随意;瞬间血;血液血浆或全血;血浆/血液;血浆或血液血清、血浆或全血;血清、血浆或血液;血清/血浆/血液血清或血浆

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94768-9

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.